Tachyphylaxis, Tolerance, & Withdrawal Post Treatment With Igalmi for Agitation in Schizophrenia or Bipolar Disorder

Conditions:   Bipolar Disorder;   Schizophrenia;   Agitation,Psychomotor;   Schizo Affective Disorder;   Schizophreniform Disorders Intervention:   Drug: Sublingual film containing Igalmi Sponsors:   BioXcel Therapeutics Inc;   Lotus Clinical Research, LLC Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials